What Happened?
Cambridge, -based Genocea Resigned Jacquelyn Sumer as Chief Legal and Compliance Officer
About the Company
Genocea is harnessing the power of T cell immunity to develop life-changing vaccines and immunotherapies. While traditional immunotherapy discovery methods have largely used predictive methods to propose T cell targets, or antigens, Genocea has successfully developed ATLAS™, its proprietary technology platform, to identify clinically relevant antigens of T cells based on actual human immune responses. Genocea is currently using ATLAS in immuno-oncology applications to develop neoantigen cancer vaccines, general cancer vaccines and a vaccine targeting cancers caused by Epstein-Barr Virus.
About the Person
Jacquelyn Sumer is Chief Legal Officer at Cullinan Oncology. Previously, Jacquelyn held various senior legal leadership roles in the industry.
Info Source
News
Short Profile